148 related articles for article (PubMed ID: 1370328)
21. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach.
Salomon L; Levrel O; Anastasiadis AG; Saint F; de La Taille A; Cicco A; Vordos D; Hoznek A; Chopin D; Abbou CC
Prostate Cancer Prostatic Dis; 2002; 5(4):285-90. PubMed ID: 12627213
[TBL] [Abstract][Full Text] [Related]
22. Radical prostatectomy and early adjuvant hormonal therapy for pTxN+ adenocarcinoma of the prostate.
Seay TM; Blute MC; Zincke H
Urology; 1997 Dec; 50(6):833-7. PubMed ID: 9426709
[No Abstract] [Full Text] [Related]
23. [The value of histochemical detection of prostate specific antigen].
Hashimoto H; Yachiku S; Nishihara M; Arima S; Tokunaka S; Inada F
Nihon Hinyokika Gakkai Zasshi; 1987 Aug; 78(8):1319-22. PubMed ID: 2449558
[No Abstract] [Full Text] [Related]
24. The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.
Carter HB; Partin AW; Epstein JI; Chan DW; Walsh PC
J Urol; 1990 Nov; 144(5):1167-70; discussion 1170-1. PubMed ID: 1700143
[TBL] [Abstract][Full Text] [Related]
25. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for stage C or D1 adenocarcinoma of the prostate: possible beneficial effect of adjuvant treatment.
Zincke H
NCI Monogr; 1988; (7):109-15. PubMed ID: 3173496
[TBL] [Abstract][Full Text] [Related]
26. Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy.
Goldrath DE; Messing EM
J Urol; 1989 Oct; 142(4):1082-4. PubMed ID: 2477560
[TBL] [Abstract][Full Text] [Related]
27. Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma.
Rainwater LM; Morgan WR; Klee GG; Zincke H
Mayo Clin Proc; 1990 Aug; 65(8):1118-26. PubMed ID: 1697014
[TBL] [Abstract][Full Text] [Related]
28. Minute focus of prostate cancer on needle biopsy: correlation with radical prostatectomy specimen.
Montanari E; Del Nero A; Gazzano G; Mangiarotti B; Bernardini P; Longo F; Cordima G; Itri E
Arch Ital Urol Androl; 2009 Mar; 81(1):9-12. PubMed ID: 19499751
[TBL] [Abstract][Full Text] [Related]
29. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.
Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A
Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439
[TBL] [Abstract][Full Text] [Related]
30. Recurrent prostate cancer despite undetectable prostate specific antigen.
Takayama TK; Krieger JN; True LD; Lange PH
J Urol; 1992 Nov; 148(5):1541-2. PubMed ID: 1279216
[TBL] [Abstract][Full Text] [Related]
31. Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate.
Oefelein MG; Smith ND; Grayhack JT; Schaeffer AJ; McVary KT
J Urol; 1997 Oct; 158(4):1460-5. PubMed ID: 9302143
[TBL] [Abstract][Full Text] [Related]
32. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
Zincke H; Utz DC; Taylor WF
J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
[TBL] [Abstract][Full Text] [Related]
33. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy.
Theodorescu D; Frierson HF; Sikes RA
J Urol; 1999 May; 161(5):1442-8. PubMed ID: 10210369
[TBL] [Abstract][Full Text] [Related]
34. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
[TBL] [Abstract][Full Text] [Related]
35. Beyond the nerve-sparing radical prostatectomy.
Smith RC; Steinberg GD; Brendler CB
Cancer Treat Res; 1996; 88():129-45. PubMed ID: 9239477
[No Abstract] [Full Text] [Related]
36. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center.
Albadine R; Hyndman ME; Chaux A; Jeong JY; Saab S; Tavora F; Epstein JI; Gonzalgo ML; Pavlovich CP; Netto GJ
Hum Pathol; 2012 Feb; 43(2):254-60. PubMed ID: 21820147
[TBL] [Abstract][Full Text] [Related]
38. False elevations in prostate-specific antigen levels affecting patient management.
Kummar S; Shafi NQ
Clin Adv Hematol Oncol; 2004 Sep; 2(9):599-601; discussion 602. PubMed ID: 16163243
[No Abstract] [Full Text] [Related]
39. Radiation therapy as adjuvant treatment after radical prostatectomy.
Lange PH; Reddy PK; Medini E; Levitt S; Fraley EE
NCI Monogr; 1988; (7):141-9. PubMed ID: 2459621
[TBL] [Abstract][Full Text] [Related]
40. Selection of patients with stage B prostate cancer for radical prostatectomy.
Middleton RG; Larsen RH
Urol Clin North Am; 1990 Nov; 17(4):779-85. PubMed ID: 1699342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
